The present disclosure relates to the field of pharmacy, particularly to a Wnt inhibitor and a PD-1 inhibitor for use in the treatment of cancer. Specifically, the disclosure relates to a pharmaceutical combination comprising a Wnt inhibitor, or a pharmaceutically acceptable salt thereof, and a PD-1 inhibitor, or a pharmaceutically acceptable salt thereof, for use in the treatment of cancer, to a method for the treatment of cancer that involves administering the combination and to the use of the combination for the manufacture of a medicament for the treatment of cancer.本發明係關於藥學領域，特別關於Wnt抑制劑及PD-1抑制劑用於治療癌症。特別地，本發明係關於一種用於治療癌症之醫藥組合，其包含Wnt抑制劑或其醫藥上可接受之鹽及PD-1抑制劑或其醫藥上可接受之鹽，關於涉及投與該組合治療癌症之方法，及關於該組合用於製造用於治療癌症之藥劑之用途。
